Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07342244 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07342244
- Sponsor
- Donghua Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2028-12-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.